MALIGHETTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.320
AS - Asia 1.921
EU - Europa 1.681
SA - Sud America 320
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 45
OC - Oceania 6
Totale 6.371
Nazione #
US - Stati Uniti d'America 2.201
IT - Italia 910
SG - Singapore 532
VN - Vietnam 467
CN - Cina 380
BR - Brasile 247
HK - Hong Kong 197
RU - Federazione Russa 168
DE - Germania 107
FR - Francia 95
BD - Bangladesh 79
CA - Canada 71
GB - Regno Unito 62
SE - Svezia 61
IN - India 54
IE - Irlanda 46
KR - Corea 43
ID - Indonesia 42
ES - Italia 41
FI - Finlandia 35
NL - Olanda 34
CH - Svizzera 31
AR - Argentina 27
JP - Giappone 27
AT - Austria 25
PL - Polonia 24
TR - Turchia 19
MX - Messico 17
ZA - Sudafrica 16
PK - Pakistan 15
EC - Ecuador 14
IQ - Iraq 13
UA - Ucraina 12
LT - Lituania 10
CR - Costa Rica 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
KE - Kenya 8
UZ - Uzbekistan 8
PE - Perù 7
CL - Cile 6
PH - Filippine 6
TH - Thailandia 5
AU - Australia 4
GT - Guatemala 4
JO - Giordania 4
TT - Trinidad e Tobago 4
AL - Albania 3
BE - Belgio 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
MU - Mauritius 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
PA - Panama 2
RO - Romania 2
SV - El Salvador 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LC - Santa Lucia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.294
Città #
Ashburn 340
Milan 319
Singapore 300
San Jose 253
Dallas 199
Hong Kong 182
Hanoi 144
Ho Chi Minh City 135
Los Angeles 101
Hefei 94
New York 84
Council Bluffs 61
Beijing 47
Columbus 45
Santa Clara 45
Dublin 44
Frankfurt am Main 44
Seoul 42
Chicago 38
Jakarta 34
The Dalles 33
Rome 32
São Paulo 30
Staranzano 29
Montreal 28
Munich 27
Boardman 26
Phoenix 26
Toronto 26
Zurich 24
Buffalo 23
Lauterbourg 22
London 22
Moscow 21
Tokyo 21
Desio 20
Seveso 20
Warsaw 19
Helsinki 17
Houston 17
Denver 16
Kent 16
Haiphong 15
Seregno 15
Chennai 14
Da Nang 14
Orem 14
Stockholm 14
Atlanta 13
Monza 13
Nuremberg 13
Brooklyn 12
Poplar 12
Turin 12
Turku 12
Amsterdam 11
Boston 11
Carate Brianza 11
Johannesburg 11
Sesto San Giovanni 11
Genoa 10
Ha Long 10
Vienna 10
Como 9
Ankara 8
Bari 8
Biên Hòa 8
Can Tho 8
Figino 8
Lesmo 8
Lissone 8
Naples 8
Paris 8
Querétaro 8
Rio de Janeiro 8
Shanghai 8
Tashkent 8
Barcelona 7
Brescia 7
Cesano Maderno 7
Chandler 7
Lima 7
Magenta 7
Quận Bình Thạnh 7
San Francisco 7
San José 7
Seattle 7
The Bronx 7
Biloxi 6
Campinas 6
Curitiba 6
Düsseldorf 6
Hải Dương 6
Ithaca 6
Lappeenranta 6
Miami 6
Newark 6
Peschiera Borromeo 6
Quận Một 6
Washington 6
Totale 3.586
Nome #
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 451
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 395
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 385
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 372
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 346
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 326
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 322
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 322
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 314
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 313
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 310
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 308
Fos rescues neuronal differentiation of sox2-deleted neural stem cells by genome-wide regulation of common sox2 and ap1(Fos-jun) target genes 289
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 281
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 260
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 255
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 253
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 228
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 178
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 166
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 135
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution 105
Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations 57
Totale 6.371
Categoria #
all - tutte 18.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 0 7 1 2
2022/202395 8 10 8 5 6 5 1 1 16 17 11 7
2023/2024284 12 6 11 13 42 58 50 11 23 14 16 28
2024/20251.446 35 80 74 61 139 73 121 55 119 221 130 338
2025/20263.597 445 295 376 478 317 172 486 159 219 321 116 213
2026/2027939 162 196 394 187 0 0 0 0 0 0 0 0
Totale 6.371